Search for Clinical Trials
Introduction: Comorbidities pose significant challenges to the delivery of quality cancer treatment. Medically underserved patients have the highest…
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
The purpose of this study is to compare existing treatment with any effects of receiving 1 year of treatment with pembrolizumab after surgery.
A study to determine if the addition of atezolizumab to chemotherapy improves response in the breast and lymph nodes in patients with triple-negative…
The purpose of this study is to find out if adding simvastatin to dual anti-HER2 treatment can slow down the growth or reduce the size of your…
This study is to see how ruxolitinib changes the breast cells when given to patients with premalignant breast conditions in order to know if it might…
The Phase 1 part of the study is being done to test the safety and effectiveness of ZN-c5 (investigational oral medication) at different dose levels…
This study is being done to see if losing weight may help prevent breast cancer from coming back.
